Endothelin is a potent mammalian vasoconstrictive peptide with structural homology to cation channel-binding insect toxins. We tested the proposal that this peptide directly activates dihydropyridine-sensitive Ca2+ channels in cultured vascular smooth muscle (VSM) cells. First, we found that cell Ca2+ can be altered in VSM by activation of voltageoperated Ca2+ channels. KCl-induced depolarization and the dihydropyridine Ca2+ channel agonist (-) Bay K 8644 (10 microM) both raised cell Ca2+ more than twofold; the effect of KCl was blocked by the inhibitory enantiomer, (+) Bay K 8644 (40 microM). Similar responses were observed in Chinese hamster ovary (CHO) cells. Synthetic endothelin (4 x 10(-8) M) raised Ca2+ in VSM but not CHO cells from 100 +/-17 to 561 +/-34 nM within 12 s. Ca2+ subsequently fell to basal levels after 30 min. Half maximal Ca2+ response was at 4 x 10(-9) M endothelin. Unlike endothelin, thrombin raised Ca2+ in both VSM and CHO cells. The Ca2+ responses to endothelin and thrombin were not affected by nicardipine (1 microM), (+) Bay K 8644, or Ca2+-free solutions. Lastly, both hormones caused release of inositol phosphates in VSM cells. However, the response to thrombin was more than 10-fold larger and was more rapid than the response to endothelin; the thrombin response was sensitive to pertussis toxin, while the response to endothelin was […] 
Introduction
Endothelin (1) is a mammalian hormone recently added to a growing list of vasoactive or growth-promoting substances that are produced by vascular endothelial cells and presumably act on the subjacent vascular smooth muscle (VSM)' cells to alter vascular tone and/or cell proliferation (for reviews, see references 2-4). Endothelin is a potent vasoconstrictor both in vitro and in vivo, capable of producing prolonged hypertension in the rat (1) . More recently, endothelin has been shown to induce the release of atrial natriuretic factor from cultured rat atrial myocytes (5) .
Among the known hormones produced by mammalian organisms, the structure of endothelin is unique: a 21 amino acid peptide with two disulfide bridges. Endothelin is almost identical to the asp venom, sarafotoxin 6B (6) , and exhibits striking homology to a-scorpion toxin, one of a family of toxins known to bind and activate the voltage-operated Na+ channel (7) . The Na+ channel has several features in common with voltage-operated Ca2`channels (8) .
Dihydropyridine-sensitive, voltage-operated Ca2' channels are found in excitable cells (8) and are believed to be responsible for the inward Ca2' current that follows membrane depolarization. This Ca2' current could activate the contractile machinery via an increase in cell Ca2'. VSM contains this type of channel, but its role in contractile function is incompletely understood. Many agents cause contraction without altering the membrane potential (9, 10) , and Ca2e channel blockade blunts the contractile response to agents that do not cause depolarization (11) . Some of these phenomena could be explained if there were biological agents that opened Ca2`channels without membrane depolarization. Bay K 8644 is such an agent (12), but it is a synthetic substance not found in biological systems.
Several lines ofevidence suggest, and indeed Yanagisawa et al. proposed (1) , that endothelin exerts its effects by activating voltage-operated Ca2" channels in VSM. First, both contraction of vascular strips (1) and release of atrial natriuretic peptide (5) were blocked by nicardipine, a Ca2l channel antagonist. Second, the contractile activity was also blocked by removal of extracellular Ca2? (1) . Lastly, endothelin has been shown to elevate Ca2" in cultured aortic smooth muscle cells and this action is partially blocked by nicardipine (13 Measurement ofCa2 i. Cells growing on the 1 X 3-cm plastic strips from the Leighton tubes were removed and mounted at a 600 angle in 1 X 1-cm acrylic fluorescence cuvettes (Sarstedt, Inc., Princeton, NJ) with a magnetic stirrer below the cell strip. The cell strips were washed three times with 2 ml of assay medium consisting of 140 mM NaCl, 5 mM KCI, 2 mM CaCl2, 1 mM Na2HPO4, 25 mM glucose, 25 mM Hepes/NaOH, and 0.5 mg/ml BSA. Cells were then incubated with 2 uM fura-2 for 40 min at 37°C and washed two times with assay medium to remove extracellular fura-2. Fluorescence (excitation wavelength = 340 or 380 nm, emission wavelength = 510 nm) was measured with a spectrofluorometer (model 8000; SLM Instruments, Inc., Urbana, IL). Excitation light was alternated between 340 and 380 nm (6-s dwell at each wavelength) with a computer controlled excitation monochromator. Background light scattering and autofluorescence were < 10% of the fluorescence signal and were subtracted during data analysis. At the end of each experiment, intracellular fura-2 was calibrated by measuring fluorescence after addition of 20 ,M 4-bromo A23 187; it was then measured again after addition of 16 mM EGTA.
[Ca2+]i was calculated using the previously described formulae (15) .
Measurement ofinositolpolyphosphate production. VSM cells were grown to confluence in 35-mm dishes with 2 ml ofmedium. To ensure a maximal response to ligands, studies were performed 3-4 d after the last change ofmedium. Phosphoinositide hydrolysis was monitored by measuring [3H]inositol phosphate accumulation with a modification (16) of the procedure originally described by Berridge et al. (17) . Briefly, the cells were labeled by incubation with [3H]myoinositol (5 MCi/dish) in culture medium for 24 h. When used, pertussis toxin (100 ng/ml) was added to the medium 4 h before the end ofincubation. The radioactive medium was aspirated and the cells were washed three times with Dulbecco PBS, 0.2% BSA (assay medium). Cells were incubated with this assay medium for I h at 37°C to remove unincorporated radioactivity. After an additional wash with assay medium, cells were preincubated with 1 ml assay medium containing 10 mM LiCl for 15 min at 37°C. Ligands were then added and incubated for the indicated times. Incubations were terminated with aspiration of medium and addition of 1 ml ice-cold 15% TCA. Cells were extracted with TCA at 4°C for 30 min. The extract was then transferred to glass tubes and the TCA was removed by five washes with 5 vol of water-saturated diethyl ether. The samples were then neutralized and separated by anion-exchange chromatography with Dowex AG1X8, formate form (Bio-Rad Laboratories). The columns were prepared in Pasteur capillary pipettes packed with 5 cm of resin. Free inositol, glycerophosphoinositol, and inositol mono-, bis-, and trisphosphates (IP, IP2, and IP3) were successively eluted with (a) 8 ml ofwater, (b) 60 mM ammonium formate/5 mM sodium tetraborate, (c) 200 mM ammonium formate/ 100 mM formic acid, (d) 450 mM ammonium formate/100 mM formic acid, and (e) I M ammonium formate/100 mM formic acid. Radioactivity was counted in a scintillation counter. IP3, as defined by this assay, actually consists of inositols 1,3,4-Tris, 1,4,5-Tris, and 1,3,4,5-tetrakisphosphate (18 In Ca2+-containing solutions, synthetic endothelin (4 X 10-8 M) raised VSM cell Ca2+ from 100± 17 to 561±34 nM within 12 s (Fig. 2) . Ca2+j then fell to basal levels over the following 30 min. The minimum dose of endothelin that gave a reproducibly detectable Ca2+ response was 1 nM (Fig. 3 A) ; the half maximal response was 4 nM (see below). The response of VSM cell Ca2+ to maximal doses of thrombin (0.4 U/ml) was almost identical to that induced by 4 X 1o-8 M endothelin (Fig. 2) . CHO cells exhibited a similar response to thrombin but, unlike VSM cells, exhibited no response to endothelin (Fig. 2) . Thus, CHO cells which exhibit dihydropyridine-sensitive Ca2" channel activity do not respond to endothelin. Furthermore, neither (+) Bay K 8644 (40 MM, Fig. 3 A) nor nicardipine (1 ,uM, not shown) altered the peak Ca2" response to endothelin or the time course for recovery of Ca2`j (Fig. 3 A) .
In Ca2+-free solutions the peak Ca2+ response to both low (10-9 M) and high (10-7 M) concentrations of endothelin was unaltered (Fig. 3 B) X 10-10 to 10-8 M (Fig. 4) In A, the bathing solution contained 2 mM Ca2+. The calcium channel antagonist, (+) Bay K 8644, blocked the response to 140 mM KCI replacement (solid line) as shown in Fig. 1 (19, 20) . As we previously found for thrombin (16) , inositol phosphate release was blocked by 4 h exposure to pertussis toxin (Fig. 5) . However, endothelin-induced release of inositol phosphate was not significantly altered by pertussis toxin treatment. Thus, the mechanism by which the endothelin receptor induces inositol phosphate release, and perhaps mobilization of Ca>, seems to be different from the mechanism used by the thrombin receptor.
Discussion
Considerable attention has recently been focused on the role of the endothelium in the control of vascular function. The endothelium appears to participate in the local control of vascular tone and in the response to vascular injury, and it may play a role in the pathogenesis of vascular diseases (2) . The endothelium exerts its effects on VSM by producing vasoactive agents and growth factors (2) . Endothelin is the most recent of these substances to be described (1) . Endothelin is a small peptide with two disulfide bridges (1). This structure is analogous to scorpion toxins which act directly on ion channels. In light of the unique structure of endothelin, we were initially intrigued by the possibility that it might be a naturally occurring agonist of the voltage-operated Ca> channel in VSM.
The findings of this paper indicate that the initial increase in Ca> induced by endothelin is not due to activation of dihydropyridine-sensitive Ca2+ channels. Unlike (-) BAY K 8644, endothelin was able to elevate cell Ca>2 normally in the absence of extracellular Ca2+, and endothelin's action was not blocked by demonstrably effective Ca2+ channel antagonists. Furthermore, endothelin failed to exhibit any affect on cell Ca2+ in a second cell line (CHO) that was shown to contain Ca> channels. These data argue against a direct action of endothelin on the Ca2+ channel. In this way endothelin is different from its structural homologue, scorpion toxin, which binds to and directly activates voltage-operated Na+ channels (7) . How then do we explain the blocking effects of nicardipine and of Ca2+-free media on endothelin's physiological effects? It is possible that endothelin's actions may lead to secondary opening of Ca> channels after the initial Ca> peak. However, such channels would have to be dihydropyridine insensitive, since dihydropyridine blockers did not alter the time course of the Ca2 i response to endothelin. Alternatively, VSM cells in situ may have properties different from those of the cells studied here.
As an initial event, endothelin appears to mobilize Ca2+j stores like another well-studied agonist, thrombin. Like thrombin, endothelin induces the release of soluble inositol phosphates. However, the details of the endothelin response differed significantly from those observed with thrombin. First, the magnitude of the inositol phosphate release by a maximal dose of endothelin M) was dramatically smaller than that released by thrombin. 10-8 M endothelin, sufficient to raise intracellular Ca2+ to its maximal level in our system, failed to induce any detectable increase in inositol phosphates.
Second, even at high concentrations of endothelin ( O0-10-6 M), the peak concentration of IP3 occurred after 30-s exposure to hormone, well after the peak level of Ca2+ had occurred (12 s). By contrast, with thrombin both events occurred at approximately the same time (10-15 s). Lastly, unlike thrombin, endothelin-induced inositol phosphate release was not sensitive to pertussis toxin. This suggests a significant difference in signal transduction for the two hormones. Since the thrombin response was only partially sensitive to pertussis toxin, it is also conceivable that thrombin uses two separate signal transduction systems.
Dissociation between the Ca2+ and inositol phosphate responses to various agents have been observed in other systems (21), but the difference between the level and time course of inositol phosphate generation by thrombin and endothelin was particularly striking, especially in view ofthe similarity oftheir Ca2+ responses. Because the assay system we used does not separate inositols 1,4,5-tris, 1,3,4-tris, and 1,3,4,5-tetrakisphosphate, it is conceivable that one of these, or another isomer might correlate more closely with the Ca2+ response. If so, the relevant isomer would have to be a minor species, because total inositol phosphates (IP3 + IP2 + IP in our assay system) were significantly lower with maximal doses of endothelin than with maximal doses of thrombin.
638
It should also be noted that increased Ca2 , can activate phospholipase C and thereby increase inositol phosphate levels (22, 23) . In HL-60 cells (a human promyelocytic cell line), the Ca2" ionophore, ionomycin, gave rise to increases in IP3 similar in magnitude (23) to those we observed with endothelin in VSM. Thus, the possibility should be considered that endothelin-induced increases in inositol phosphates are the consequence rather than the cause of increased Ca2? by endothelin.
In any event, the relationship between release of IP3 and intracellular stores ofCa2. does not appear to be simple. Because of the striking dissociation between IP3 production and Ca2+ mobilization by endothelin, this agent may be useful in further studies on the mechanisms of Ca2 , mobilization by peptide hormones.
